191602-42-3

Usage

Uses

Used in Pharmaceutical Industry:
2-Bromo-1-isopropoxy-4-nitrobenzene is used as an intermediate in organic synthesis for the production of pharmaceuticals. Its unique structure allows for the creation of various drug molecules, contributing to the development of new medications.
Used in Agrochemical Industry:
In the agrochemical sector, 2-Bromo-1-isopropoxy-4-nitrobenzene serves as an intermediate in the synthesis of agrochemicals. Its properties enable the production of effective compounds for crop protection and pest control.
Used in Fine Chemicals Industry:
2-Bromo-1-isopropoxy-4-nitrobenzene is also utilized as an intermediate in the synthesis of other fine chemicals. Its versatility in organic synthesis makes it valuable for the production of specialty chemicals used in various applications, such as fragrances, dyes, and coatings.

Upstream product

• 5847-59-6 2-bromo-4-nitrophenol 
• 67-63-0 isopropyl alcohol 
• 75-30-9 2-iodo-propane 

Downstream Products

• 921194-46-9 4-isopropoxy-3-vinylaniline 
• 191602-43-4 3-bromo-4-isopropoxyaniline 

Relevant academic research and scientific papers

BETA-SUBSTITUTED BETA-AMINO ACIDS AND ANALOGS AS CHEMOTHERAPEUTIC AGENTS AND USES THEREOF

β-Substituted β-amino acids, β-substituted β-amino acid derivatives, and β-substituted β-amino acid analogs and (bio)isosteres and their use as chemotherapeutic agents are disclosed. The β-substituted β-amino acid derivatives and β-substituted β-amino acid analogs and (bio)isosteres are selective LAT1/4F2hc substrates and exhibit rapid uptake and retention in tumors expressing the LAT1/4F2hc transporter. Methods of synthesizing the β-substituted β-amino acid derivatives and β-substituted β-amino acid analogs and methods of using the compounds for treating cancer are also disclosed. The β-substituted β-amino acid derivatives and β-substituted β-amino acid analogs exhibit selective uptake in tumor cells expressing the LAT1/4F2hc transporter and accumulate in cancerous cells when administered to a subject in vivo. The β-substituted β-amino acid derivatives and β-substituted β-amino acid analogs and (bio)isosteres exhibit cytotoxicity toward several tumor types.

Synthesis and antiprotozoal activity of dicationic m-terphenyl and 1,3-dipyridylbenzene derivatives

4,4″-Diamidino-m-terphenyl (1) and 36 analogues were prepared and assayed in vitro against Trypanosoma brucei rhodesiense, Trypanosoma cruzi, Plasmodium falciparum, and Leishmania amazonensis. Twenty-three compounds were highly active against T. b. rhodesiense or P. falciparum. Most noteworthy were amidines 1, 10, and 11 with IC50 of 4 nM against T. b. rhodesiense, and dimethyltetrahydropyrimidinyl analogues 4 and 9 with IC50 values of ≤ 3 nM against P. falciparum. Bis-pyridylimidamide derivative 31 was 25 times more potent than benznidazole against T. cruzi and slightly more potent than amphotericin B against L. amazonensis. Terphenyldiamidine 1 and dipyridylbenzene analogues 23 and 25 each cured 4/4 mice infected with T. b. rhodesiense STIB900 with four daily 5 mg/kg intraperitoneal doses, as well as with single doses of ≤10 mg/kg. Derivatives 5 and 28 (prodrugs of 1 and 25) each cured 3/4 mice with four daily 25 mg/kg oral doses.

Activated pyridinium-tagged ruthenium complexes as efficient catalysts for ring-closing metathesis

New pyridinium-tagged ruthenium catalysts have been synthesised to perform olefin metathesis in several media including both organic and aqueous solvents and room temperature ionic liquids (RTILs). High activity was obtained in the ring-closing metathesis (RCM) of a variety of di- or tri-substituted and/or oxygen-containing dienes. However, only fair levels of recycling combined with low to moderate residual ruthenium levels (25-173 ppm) have been observed showing clearly the difficulty of associating high activity and recyclability.